Age-Related Changes in RNA Quality Control

RNA molecules are repeatedly checked as they are made, processed, exported, translated, and degraded. These checks include transcriptional proofreading, nuclear RNA turnover, nonsense-mediated decay (NMD), nonstop decay, no-go decay, and pathways that release stalled ribosomes and dispose of the associated RNA and incomplete protein. Together, they reduce the persistence or translation of faulty transcripts while also regulating some normal RNAs. [1]

Who This Is Useful For

This page is for readers who want to understand how RNA maintenance differs from DNA repair and protein quality control, where age-related changes have been measured, and why findings from worms, yeast, cultured cells, and human tissues do not all carry the same evidential weight.

Quality Control Begins During RNA Production

RNA quality depends partly on how accurately and at what speed RNA polymerase copies DNA. In ageing yeast cells, transcription errors became more frequent; experimentally increasing the error rate caused proteotoxic stress and shortened replicative lifespan. This established a causal link in yeast, not a measured rate of transcription errors in ageing humans. [2]

A cross-species study found that average RNA polymerase II elongation speed increased with age in worms, flies, mice, rats, human blood, and senescent human cell models. Faster elongation was accompanied by changes in transcript processing, including splicing and circular RNA formation. Slowing the polymerase genetically increased lifespan in worms and flies, whereas the human evidence concerned blood or cells rather than organismal lifespan. [3]

Surveillance of Premature Stop Signals

NMD recognizes many messenger RNAs on the basis of an abnormally placed translation stop signal and recruits degradation machinery. It also regulates a subset of normal transcripts, so greater or lower NMD activity is not simply equivalent to better or worse RNA quality in every context. [1] [4]

In C. elegans, reporter measurements showed that NMD activity declined with age in several tissues. Long-lived worms with reduced insulin/IGF-1 signalling maintained higher NMD activity, and disrupting core NMD components reduced their lifespan extension. These experiments show that RNA surveillance can contribute causally to longevity in this model, but they do not demonstrate the same age trajectory or lifespan effect in humans. [4]

Stalled Ribosomes Link RNA and Protein Quality Control

No-go decay and ribosome-associated quality control respond when translation slows or stalls. The response separates the ribosomal subunits, degrades problematic RNA or nascent protein, and recycles translation machinery; these events connect RNA surveillance directly with proteostasis. [1] [5]

Ribosome profiling found that pausing at particular sequence contexts increased with age in yeast and worms. In worms, proteins encoded by transcripts with age-dependent pause sites were strongly enriched among age-associated protein aggregates. The study supports a mechanistic connection between altered translation kinetics and proteostasis decline, although it does not establish that every stall reflects failed RNA surveillance. [5]

More recent work found age-related declines in the ribosome-rescue factor Pelota in worms and examined related effects in human cells and mice. Increasing Pelota activity improved several ageing-associated phenotypes in those experimental systems. This broadens the evidence beyond invertebrates, but it remains preclinical and does not show that Pelota decline is a universal driver of human ageing. [9]

Layers of RNA Quality Control

Damaged RNA and Abnormal RNA Fragments

RNA can be chemically damaged as well as produced or processed incorrectly. In post-mortem human cortex, neuronal staining for the oxidized RNA nucleoside 8-hydroxyguanosine increased across adult age groups and was particularly prominent at the earliest examined stage of cognitive impairment. Because this was an observational brain study spanning normal ageing and Alzheimer disease transition, it cannot by itself determine whether RNA oxidation is a cause, consequence, or marker of neuronal stress. [8]

Another study found isolated 3′ untranslated-region RNA fragments in ageing mouse neurons and age-associated patterns in human brain RNA datasets. Experiments that reduced the oxidation-sensitive ribosome-recycling factor ABCE1 produced similar fragments, supporting a model involving stalled ribosomes and RNA cleavage. The authors also noted that other routes could generate the fragments, so their presence is evidence of altered RNA handling rather than a unique readout of one failed pathway. [6]

Nuclear RNA Turnover and Senescence

The nuclear RNA exosome processes or degrades many classes of RNA. In cultured embryonic stem cells, acute depletion of exosome components caused nuclear RNA aggregation, disrupted transcription and translation, and eventually produced features of a pre-senescent state. Exosome expression was also reduced in the senescence datasets examined by the study. These results show that disturbed nuclear RNA homeostasis can help drive a senescence-like transition in cells, but cellular senescence is not interchangeable with normal organismal ageing. [7]

Evidence Quality and Interpretation

Confidence is strongest that particular RNA-production, surveillance, and translation-control processes change with age in defined experimental systems. Independent studies have measured age-related changes in transcriptional kinetics, NMD activity, ribosome pausing, RNA oxidation, and abnormal RNA fragments. [3] [4] [5] [6] [8]

Confidence is lower that these findings constitute one coordinated decline across all human tissues. The causal lifespan experiments rely mainly on yeast, worms, and flies; cultured-cell depletion can be more abrupt than physiological ageing; and human tissue studies are generally observational and tissue-specific. Mouse and human-cell findings for Pelota add cross-species support but remain preclinical. [2] [3] [4] [7] [9]

What This Does Not Mean

• It does not mean that every age-associated RNA difference is an error; NMD and other decay pathways also regulate normal transcripts. [1] [4]
• It does not mean that altered splicing, transcription speed, RNA oxidation, and ribosome stalling are the same defect; they occur at different stages and are measured differently. [3] [5] [8]
• It does not establish that RNA quality-control decline is a single primary cause of human ageing; current causal evidence is concentrated in experimental models. [2] [4] [9]
• It does not show that experimentally increasing one surveillance component would be beneficial or safe in people, because these pathways also control normal gene expression. [1] [4]

Practical Interpretation Examples

• If a worm study reports declining NMD with age: this demonstrates an age trajectory in that organism, not a validated blood or tissue biomarker for people. [4]
• If an older brain contains more RNA fragments: that supports altered RNA handling, but tissue region, oxidative stress, disease status, and the fragment-producing mechanism still matter. [6] [8]
• If a factor rescues a cell or animal phenotype: this strengthens causal evidence in that model but does not establish a human intervention. [3] [9]

Summary

Ageing is associated with measurable changes at several stages of RNA maintenance: transcription can become less controlled, NMD activity can decline, ribosome stalls can increase, and damaged or unusual RNA species can accumulate. Experimental manipulation shows that some of these changes can affect cellular or organismal ageing in model systems. The human evidence is narrower and mostly observational, so RNA quality control is best understood as a set of interacting, context-dependent processes rather than a single established driver or biomarker of human ageing. [2] [3] [4] [5] [6] [9]

References

1. Isken, O., & Maquat, L. E. (2007). Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function. Genes & Development. https://genesdev.cshlp.org/content/21/15/1833.long
2. Vermulst, M., et al. (2015). Transcription errors induce proteotoxic stress and shorten cellular lifespan. Nature Communications. https://www.nature.com/articles/ncomms9065
3. Debès, C., et al. (2023). Ageing-associated changes in transcriptional elongation influence longevity. Nature. https://www.nature.com/articles/s41586-023-05922-y
4. Son, H. G., et al. (2017). RNA surveillance via nonsense-mediated mRNA decay is crucial for longevity in daf-2/insulin/IGF-1 mutant C. elegans. Nature Communications. https://www.nature.com/articles/ncomms14749
5. Stein, K. C., et al. (2022). Ageing exacerbates ribosome pausing to disrupt cotranslational proteostasis. Nature. https://www.nature.com/articles/s41586-021-04295-4
6. Sudmant, P. H., et al. (2018). Widespread accumulation of ribosome-associated isolated 3′ UTRs in neuronal cell populations of the aging brain. Cell Reports. https://pmc.ncbi.nlm.nih.gov/articles/PMC6354779/
7. Han, X., et al. (2024). Nuclear RNA homeostasis promotes systems-level coordination of cell fate and senescence. Cell Stem Cell. https://doi.org/10.1016/j.stem.2024.03.015
8. Nunomura, A., et al. (2012). The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons. Journal of Neuropathology & Experimental Neurology. https://pmc.ncbi.nlm.nih.gov/articles/PMC3288284/
9. Lee, J., et al. (2025). Pelota-mediated ribosome-associated quality control counteracts aging and age-associated pathologies across species. Proceedings of the National Academy of Sciences. https://pmc.ncbi.nlm.nih.gov/articles/PMC12358915/